Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice (Q34097557)

31 July 2017

title

Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice (English)

1 reference

31 July 2017

1 reference

1 reference

Patrick Soussan

14

0 references

Olivier Hantz

object named as

Olivier Hantz

13

0 references

Johan Neyts

object named as

Johan Neyts

12

0 references

Laurent Hannoun

9

object named as

Laurent Hannoun

1 reference

31 July 2017

16

Dina Kremsdorf

1 reference

31 July 2017

Nicolas Brezillon

1

1 reference

31 July 2017

Marie-Noëlle Brunelle

2

1 reference

31 July 2017

Hélène Massinet

3

1 reference

31 July 2017

Eric Giang

4

1 reference

31 July 2017

Céline Lamant

5

1 reference

31 July 2017

Lucie DaSilva

6

1 reference

31 July 2017

Sophie Berissi

7

1 reference

31 July 2017

Jacques Belghiti

8

1 reference

31 July 2017

Gherard Puerstinger

10

1 reference

31 July 2017

Eva Wimmer

11

1 reference

31 July 2017

Serban Morosan

15

1 reference

31 July 2017

language of work or name

English

0 references

publication date

5 December 2011

1 reference

31 July 2017

1 reference

31 July 2017

volume

6

1 reference

31 July 2017

issue

12

1 reference

31 July 2017

page(s)

e25096

1 reference

Creative Commons Attribution 4.0 International

31 July 2017

copyright license

start time

5 December 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3230577

Hepatitis B: the virus and disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3230577

Benefits and risks of interferon therapy for hepatitis B.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3230577

Benefits and risks of nucleoside analog therapy for hepatitis B.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3230577

Hepatitis B virus induced hepatocellular carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3230577

Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3230577

The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3230577

Hepatitis B: reflections on the current approach to antiviral therapy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3230577

NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3230577

The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3230577

Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3230577

A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3230577

Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3230577

Near completely humanized liver in mice shows human-type metabolic responses to drugs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3230577

Antivirals interacting with hepatitis B virus core protein and core mutations may misdirect capsid assembly in a similar fashion

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3230577

The Alkylated Imino Sugar, n -( n -Nonyl)-Deoxygalactonojirimycin, Reduces the Amount of Hepatitis B Virus Nucleocapsid in Tissue Culture

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3230577

Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3230577

A small molecule inhibits and misdirects assembly of hepatitis B virus capsids

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3230577

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3230577

Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model

5 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0025096

An in vitro fluorescence screen to identify antivirals that disrupt hepatitis B virus capsid assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0025096

BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0025096

Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0025096

Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0025096

Rescue of fertility in homozygous mice for the urokinase plasminogen activator transgene by the transplantation of mouse hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0025096

Liver-stage development of Plasmodium falciparum, in a humanized mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0025096

Expression of defective hepatitis B virus particles derived from singly spliced RNA is related to liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0025096

10.1371/JOURNAL.PONE.0025096

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

0 references

1 reference

31 July 2017

1 reference